SOLID TUMOR MALIGNANCIES
Clinical trials for SOLID TUMOR MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR MALIGNANCIES trials appear
Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise against Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests an experimental drug called TYK-01054 for people with advanced solid tumors that have not responded to standard treatments. The drug works by blocking a protein called TEAD, which may help slow or stop tumor growth. The trial will enroll 219 adults and focus on s…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New hope for advanced cancer patients: experimental drug ZE94-0605 enters first human trial
Disease control Not yet recruitingThis early-phase study tests an experimental drug called ZE94-0605 in about 60 adults with advanced solid tumors that have not responded to or are not eligible for standard treatments. The main goals are to find the safest dose and to see if the drug can shrink tumors. The study …
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New mRNA vaccine takes on advanced cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a personalized mRNA vaccine (RH125) in 36 adults with advanced solid tumors who have run out of standard options. The vaccine is designed to train the immune system to attack each person's unique cancer. Researchers will check safety, immune response,…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Could a common fruit acid boost cancer immunotherapy?
Disease control Not yet recruitingThis early-phase study tests whether adding malic acid (a natural fruit acid) to standard immunotherapy is safe and helps control tumors in people with solid cancers like colorectal, lung, or melanoma. About 30 adults currently on immunotherapy will take oral malic acid. Research…
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Can a simple test predict who will have dangerous reactions to immunotherapy?
Knowledge-focused Not yet recruitingThis study looks for a way to predict which cancer patients will have severe side effects from immunotherapy drugs. Researchers will collect blood, stool, and imaging data from 160 adults with solid tumors before and during treatment. The goal is to create a 'signature' that can …
Matched conditions: SOLID TUMOR MALIGNANCIES
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
Can a blood test predict Cancer-Related anxiety?
Knowledge-focused Not yet recruitingThis study aims to find biological markers in tumor tissue and blood that are linked to anxiety and depression in people with solid tumors. Researchers will combine psychological assessments with lab tests to identify proteins from tumors that may affect mood. The goal is to crea…
Matched conditions: SOLID TUMOR MALIGNANCIES
Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC